Retraction brain ischaemia: mannitol plus nimodipine preserves both cerebral blood flow and evoked potentials during normoventilation and hyperventilation.
In our miniature swine model simulating operating room brain retraction, we investigated the effects of mannitol plus nimodipine on cerebral blood flow (CBF) and evoked potentials (EP) ipsilateral and contralateral to retraction, in comparison with either agent alone, during both normoventilation and hyperventilation. We here report results in 27 animals with intravenous mannitol (2 g kg-1 over 15 min) and/or nimodipine (1 microgram kg-1 min-1 constant infusion). Mannitol plus nimodipine was superior both to controls and to either mannitol alone or nimodipine alone in preserving EP amplitude ipsilateral to retraction during both normoventilation and hyperventilation. Mannitol alone was effective in normoventilation at preserving EP, while nimodipine alone was effective in hyperventilation. No significant asymmetries in CBF or EP were seen with mannitol plus nimodipine in either normoventilation or hyperventilation. By five minutes postretraction CBF had returned to preretraction values for all groups, and EP amplitude had returned also except for hyperventilated controls. In this model of brain retraction, mannitol plus nimodipine is superior to either agent alone in maintaining both CBF and EP when normoventilation and hyperventilation are employed. The results are discussed in terms of the possible mechanisms for the different and complementary effects of mannitol and nimodipine.
Andrews
R J
RJ
Department of Neurological Surgery, University of California, Davis.
Muto
R P
RP
D000818:Animals; D001794:Blood Pressure / Q000502:physiology; D001921:Brain / Q000601:surgery*; D002245:Carbon Dioxide / Q000378:metabolism; D002560:Cerebrovascular Circulation / Q000187:drug effects; D004359:Drug Therapy, Combination; D005071:Evoked Potentials / Q000187:drug effects; D006863:Hydrogen-Ion Concentration; D006985:Hyperventilation / Q000503:physiopathology; D007431:Intraoperative Complications / Q000188:drug therapy*; D002546:Ischemic Attack, Transient / Q000188:drug therapy*; D008353:Mannitol / Q000008:administration & dosage*; D009553:Nimodipine / Q000008:administration & dosage*; D011312:Pressure; D013552:Swine; D013556:Swine, Miniature
D002245:Carbon Dioxide; D008353:Mannitol; D009553:Nimodipine